Results 11 to 20 of about 454,627 (348)
The “breakthrough therapy” designation (BTD) is a recent mechanism implemented by the United States Food and Drug Administration (FDA) to expedite access to drugs that address unmet needs.
Megan C. Herink +4 more
doaj +1 more source
Pharmacogenomics, which is defined as the study of changes in the properties of DNA and RNA associated with drug response, enables the prediction of the efficacy and adverse effects of drugs based on patients’ specific genetic mutations. For the safe and
Mijin Lee +6 more
doaj +1 more source
Community Labeling: Former Drug Convicts Become Drug Convicts Again
This research was motivated by the discovery of information about ex-drug convicts at Class IIB Padang prison who returned to drug convicts after repeating the same incident.
Mira Hasti Hasmira, Suhai Ratu Rahmi
doaj +1 more source
A survey of Top 200 Drugs—Inconsistent Practice of Drug Strength Expression for Drugs Containing Salt Forms [PDF]
Many ionizable drugs are developed and marketed as salt forms. However, there are no clear US regulatory guidelines on drug strength labeling for salts. The strengths of some drugs are expressed as salts and some as free acids/bases.
Prohotsky, Daniel, Zhao, Fang
core +2 more sources
Fair Hearing in Administrative Rule-Making: A Recent Experience Under the Federal Food, Drug, and Cosmetic and Fair Packaging and Labeling Acts [PDF]
In promulgating regulations to govern the labeling of foods under the Fair Packaging and Labeling Act, the Commissioner of Food and Drugs, despite the objections of adversely affected parties, denied all requests for a public hearing. In this article the
Forte, Wesley E.
core +2 more sources
Nutrition Labeling in the United States and the Role of Consumer Processing, Message Structure, and Moderating Conditions [PDF]
It has been since 1990 that the landmark Nutritional Labeling Education Act (NLEA) was passed in the United States, and since 1969 that the first White House Conference on Food, Nutrition and Health occurred.
Andrews, J. Craig +2 more
core +2 more sources
Background: Recent studies in several countries show a significant decrease in the consumption of osteoporosis drugs from a peak around 2009, mainly attributed to bisphosphonate safety warnings issued by regulatory agencies on jaw osteonecrosis, atypical
Isabel Hurtado-Navarro +11 more
doaj +1 more source
Since 1997, studies have found that Asians need lower clozapine doses than Caucasians. Caucasians with average clozapine metabolism may need from 300 to 600 mg/day to reach the therapeutic range (350 ng/ml). Thus, serum clozapine concentration-to-dose (C/
Jose de Leon +12 more
doaj +1 more source
Guessability of U.S. pharmaceutical pictograms in Iranian prospective users
Objective: This study examined the gueassability of US pharmaceutical pictograms as well as associated demographic factors and cognitive design features among Iranian adults. Methods: A total of 400 participants requested to guess the meaning of 53 US
Mahnaz Saremi +2 more
doaj +1 more source
Cardiovascular Drug Labeling: Do They Have Information on Necessary Precautions for Older People? [PDF]
OBJECTIVE: To analyze the existence of information on drug labeling intended for health professionals on the precaution of cardiovascular drugs use in older people.
Lucas Oliveira Marques +4 more
doaj +1 more source

